This week’s #FounderFriday is Gregory Stein, CEO and President of Curtana Pharmaceuticals. Curtana Pharmaceuticals is a preclinical-stage company focused on developing first-in-class small molecule therapeutics that directly target and kill cancer stem cells (CSCs) for the treatment of brain cancer, including glioblastoma (GBM) in adults and pediatric high grade glioma (pHGG) in children. We are thrilled to have Gregory #tellyourstory and Curtana Pharmaceuticals be a part of#thescienceofinvesting.
Where are you from:
What is your favorite restaurant to eat at for a business meeting:
What is the best book you have read in the last 6 months:
I have two kids under the age of 5. Who has time to read a book?!
When I am not in the office, I am…..
Spending time with my family or at the gym.
Find the best in healthcare innovation. Join angelMD today.